Literature DB >> 19748429

Clinical failure of vancomycin in a dialysis patient with methicillin-susceptible vancomycin-heteroresistant S. aureus.

Dahlene N Fusco1, Elizabeth L Alexander, Scott A Weisenberg, Jose R Mediavilla, Barry N Kreiswirth, Audrey N Schuetz, Stephen G Jenkins, Kyu Y Rhee.   

Abstract

We report a case of recurrent Staphylococcus aureus bacteremia in a patient who failed vancomycin due to a vancomycin-heteroresistant strain lacking methicillin resistance. Although initial isolates were susceptible, isolates obtained after vancomycin chemotherapy were vancomycin heteroresistant. This case thus illustrates the clinical emergence of vancomycin heteroresistance.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19748429      PMCID： PMC5227555          DOI： 10.1016/j.diagmicrobio.2009.05.017

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  12 in total

1.  The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

Authors:  K Sieradzki; R B Roberts; S W Haber; A Tomasz
Journal:  N Engl J Med       Date:  1999-02-18       Impact factor: 91.245

2.  Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis.

Authors:  M R Mulvey; L Chui; J Ismail; L Louie; C Murphy; N Chang; M Alfa
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

3.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

4.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

5.  A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides.

Authors:  Mandy Wootton; Alasdair P MacGowan; Timothy R Walsh; Robin A Howe
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

6.  Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative.

Authors:  S Bobin-Dubreux; M E Reverdy; C Nervi; M Rougier; A Bolmström; F Vandenesch; J Etienne
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

7.  Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.

Authors:  Patrick G P Charles; Peter B Ward; Paul D R Johnson; Benjamin P Howden; M Lindsay Grayson
Journal:  Clin Infect Dis       Date:  2004-01-12       Impact factor: 9.079

8.  Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007).

Authors:  Michael J Rybak; Steve N Leonard; Kerri L Rossi; Chrissy M Cheung; Helio S Sader; Helio S Sadar; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2008-07-16       Impact factor: 5.948

Review 9.  Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.

Authors:  George Sakoulas; Robert C Moellering
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

10.  Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.

Authors:  Louis Bernard; Pierre Vaudaux; Peter Rohner; Elzbieta Huggler; Mathieu Armanet; Didier Pittet; Daniel P Lew; Jacques Schrenzel
Journal:  J Microbiol Methods       Date:  2004-05       Impact factor: 2.363
View more
  10 in total

Review 1.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

2.  Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  Wessam Abdelhady; Arnold S Bayer; Kati Seidl; Cynthia C Nast; Megan R Kiedrowski; Alexander R Horswill; Michael R Yeaman; Yan Q Xiong
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

3.  Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  Kati Seidl; Liang Chen; Arnold S Bayer; Wessam Abdel Hady; Barry N Kreiswirth; Yan Q Xiong
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

4.  Frequent occurrence of trimethoprim-sulfamethoxazole hetero-resistant Staphylococcus aureus isolates in different African countries.

Authors:  C Coelho; H de Lencastre; M Aires-de-Sousa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-03       Impact factor: 3.267

5.  In vitro endothelial cell damage is positively correlated with enhanced virulence and poor vancomycin responsiveness in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Authors:  Kati Seidl; Arnold S Bayer; James A McKinnell; Steven Ellison; Scott G Filler; Yan Q Xiong
Journal:  Cell Microbiol       Date:  2011-07-21       Impact factor: 3.715

6.  Treatment considerations for recurrent MRSA bacteremia leading to cholecystitis.

Authors:  Jenna Martin; Daniella Miller; Geraldine E Ménard
Journal:  J Gen Intern Med       Date:  2011-01-19       Impact factor: 5.128

7.  Endovascular infections caused by methicillin-resistant Staphylococcus aureus are linked to clonal complex-specific alterations in binding and invasion domains of fibronectin-binding protein A as well as the occurrence of fnbB.

Authors:  Yan Q Xiong; Batu K Sharma-Kuinkel; Nadia N Casillas-Ituarte; Vance G Fowler; Thomas Rude; Alex C DiBartola; Roberto D Lins; Wessam Abdel-Hady; Steven K Lower; Arnold S Bayer
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

8.  A Dual-Function Antibiotic-Transporter Conjugate Exhibits Superior Activity in Sterilizing MRSA Biofilms and Killing Persister Cells.

Authors:  Alexandra Antonoplis; Xiaoyu Zang; Melanie A Huttner; Kelvin K L Chong; Yu B Lee; Julia Y Co; Manuel R Amieva; Kimberly A Kline; Paul A Wender; Lynette Cegelski
Journal:  J Am Chem Soc       Date:  2018-11-14       Impact factor: 15.419

9.  Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report.

Authors:  Beatriz Perazzi; Natalia Bello; Marta Mollerach; Carlos Vay; María Beatriz Lasala; Angela Famiglietti
Journal:  J Med Case Rep       Date:  2011-07-07

10.  Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075.

Authors:  Sarah E Anderson; Edgar X Sherman; David S Weiss; Philip N Rather
Journal:  mSphere       Date:  2018-08-15       Impact factor: 4.389
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.